NAVLE Reproductive

Equine Retained Placenta and Placentitis – NAVLE Study Guide

Retained fetal membranes (RFM) and placentitis represent two of the most clinically significant reproductive conditions in equine practice.

Overview and Clinical Importance

Retained fetal membranes (RFM) and placentitis represent two of the most clinically significant reproductive conditions in equine practice. Retained placenta occurs when the fetal membranes fail to be expelled within 3 hours postpartum, and is considered a veterinary emergency due to the potential for life-threatening complications including metritis, laminitis, septicemia, and death. Placentitis, inflammation of the placenta typically due to ascending bacterial infection, is responsible for up to 30% of late-term pregnancy losses in mares. Understanding the pathophysiology, diagnosis, and treatment of these conditions is essential for NAVLE success and clinical practice.

Structure Description Clinical Significance
Chorioallantois Outer membrane with velvety red chorionic surface (microcotyledons) and smooth white allantoic surface Nearly entire surface must attach for adequate fetal support; only one fetus can be fully supported
Cervical Star Pale, smooth avillous area at cervix where placenta lacks microcotyledons Normal rupture site during foaling; most common site of ascending infection; assessed in CTUP measurement
Nongravid Horn Thinner, puckered portion of placenta that did not contain fetus Most commonly retained portion; always examine tip for completeness
Amnion Inner membrane directly surrounding fetus; white, avascular Should rupture during foaling revealing foal; attached to umbilical cord
Hippomanes Allantoic calculus; brown, liver-like concretion in allantoic fluid Normal finding; composed of cellular debris and minerals

Normal Equine Placental Anatomy

The equine placenta is classified as diffuse, microcotyledonary, and epitheliochorial. This means the entire surface of the chorioallantois attaches to the endometrium through millions of microscopic finger-like projections called microcotyledons, and six tissue layers separate maternal and fetal circulations. This placental arrangement has critical clinical implications.

Key Anatomical Features and Clinical Significance

Placental Examination: The F-Shape Method

Every placenta should be examined immediately after expulsion. Lay the membranes out in an "F" shape with the chorionic (red, velvety) surface exposed. The bottom leg represents the cervical end with the cervical star rupture site. The vertical portion corresponds to the uterine body. The upper arm (longer, thicker) represents the gravid horn, and the lower arm (thinner, wrinkled) represents the nongravid horn. Normal placental weight should be approximately 11% of foal body weight.

High-YieldThe nongravid horn tip is the most commonly retained portion of the equine placenta. Even small retained fragments can cause life-threatening complications identical to complete retention. Always examine both horn tips carefully for completeness.
Risk Factor Mechanism/Notes
Breed: Friesian, Draft breeds Up to 50% incidence; possible genetic predisposition affecting placental detachment
Dystocia Uterine fatigue and trauma; associated with increased tissue inflammation
Cesarean section/Fetotomy Surgical manipulation disrupts normal hormonal cascade and uterine contractility
Prolonged gestation Placental aging and increased adhesion to endometrium
Placentitis Inflammation increases adhesion; edematous tissue difficult to detach
Abortion Incomplete hormonal preparation for parturition
Induced parturition Bypasses normal endocrine preparation for placental release
Hydrops Uterine overdistension leads to myometrial fatigue
Advanced maternal age Decreased uterine tone and contractility; endometrial fibrosis
History of RFM Increased recurrence risk; consider prophylactic oxytocin

Retained Fetal Membranes (RFM)

Definition and Incidence

Retained fetal membranes are defined as failure to expel the chorioallantois within 3 hours postpartum. Normal expulsion typically occurs within 30 minutes to 1 hour, with 95% of mares expelling membranes within 4 hours. The overall incidence ranges from 2-10% in light horse breeds, but is significantly higher in Friesian and heavy draft breeds where incidence may reach up to 50%.

Pathophysiology

The exact cause of RFM is not fully understood, but involves failure of the microcotyledonary attachments to release from endometrial crypts. Normally, postpartum uterine contractions stimulated by oxytocin facilitate separation of the microvilli. Proposed contributing factors include uterine inertia from hormonal imbalances (particularly low oxytocin), calcium and phosphorus imbalances, dysregulation of extracellular matrix remodeling, and placental edema or inflammation.

Risk Factors

Clinical Signs and Diagnosis

Diagnosis of complete retention is straightforward when membranes are visible protruding from the vulva. However, partial retention may not be obvious and is equally dangerous. Clinical signs develop as bacterial growth and toxin absorption progress.

Early Signs (less than 12 hours)

  • Visible membranes hanging from vulva (may be absent with partial retention)
  • Mare may appear normal initially
  • Mild discomfort or straining

Progressive Signs (12-24 hours)

  • Fever (greater than 38.5C / 101.5F)
  • Depression and anorexia
  • Fetid vulvar discharge
  • Congested or muddy mucous membranes
  • Signs of endotoxemia

Severe Complications

  • Laminitis: May develop as early as 8 hours; secondary to endotoxemia affecting laminar blood flow
  • Toxic metritis: Gram-negative bacterial overgrowth with massive endotoxin release
  • Septicemia: Systemic bacterial infection from uterine absorption
  • Death: Without treatment, mortality significantly increases after 12-24 hours
High-YieldRFM in horses is a TRUE EMERGENCY - unlike cattle where retained placenta is often managed conservatively. The diffuse placental attachment means massive surface area for bacterial growth and toxin absorption. Treatment should begin by 3 hours postpartum, with aggressive intervention if membranes not passed by 6-8 hours.

Treatment of Retained Fetal Membranes

Treatment goals are threefold: (1) facilitate placental expulsion, (2) prevent systemic complications including endotoxemia and laminitis, and (3) preserve future fertility.

Manual Removal: Controversy and Risks

Manual removal of retained placenta is controversial and generally NOT recommended unless the membranes are almost completely detached. Complications include uterine hemorrhage, endometrial damage, uterine horn invagination/intussusception, uterine prolapse, pulmonary emboli, placental tearing leaving retained tags, and delayed uterine involution. If attempted, use gentle twisting motion while applying minimal traction - never pull forcefully downward.

NAVLE TipKey time points for NAVLE: Placenta retained if not passed by 3 hours. Initiate oxytocin by 3-6 hours. Start antibiotics and NSAIDs if not passed by 8-12 hours. Laminitis can develop as early as 8 hours. Treatment intensifies progressively - never "wait and see" in horses!
Treatment Dose/Protocol Mechanism Notes
Oxytocin (First-line) Bolus: 10-20 IU IV/IM q30min-2h OR Drip: 30-100 IU in 1L saline over 30-60 min Stimulates uterine contractions; releases microvilli from crypts Avoid greater than 20 IU bolus (causes tetanic spasm). Successful in up to 90% of cases
Calcium gluconate 120-150 mL 23% with oxytocin in IV fluids Enhances myometrial contractility; mares with RFM often hypocalcemic Administer slowly IV; improves oxytocin response
Burns Technique Fill chorioallantois with 8-12L warm sterile saline or dilute povidone-iodine for 15-30 min Weight stretches uterus; stimulates endogenous oxytocin release; facilitates detachment Use with exogenous oxytocin; tie off cervical end to retain fluid
Umbilical vessel infusion Inject water/saline into umbilical vessels Vessel expansion promotes detachment of microvilli Safe, gentle, rapid method
Uterine lavage 10-12L warm saline/LRS; repeat 1-2x daily until clear Removes bacteria, toxins, debris; stimulates contractions Essential after membrane removal; continue until minimal fluid accumulates
Antibiotics Penicillin 22,000 IU/kg IV QID + Gentamicin 6.6 mg/kg IV SID OR TMS 30 mg/kg PO BID +/- Metronidazole 15-25 mg/kg PO BID Broad-spectrum coverage; target Strep. zooepidemicus, E. coli, anaerobes Start if membranes not passed by 8-12 hours; minimum 5 days therapy
Flunixin meglumine 1.1 mg/kg IV BID-TID COX inhibitor; anti-inflammatory; anti-endotoxic Critical for endotoxemia prevention; start early
Laminitis prevention Continuous foot icing for up to 72 hours; supportive footing; pentoxifylline Cryotherapy prevents laminar inflammation; pentoxifylline improves microcirculation ESSENTIAL - laminitis is most devastating complication
Tetanus prophylaxis Tetanus toxoid or antitoxin based on vaccination status Uterine environment is anaerobic - tetanus risk Required in all RFM cases

Placentitis

Definition and Types

Placentitis is inflammation of the placenta, most commonly due to bacterial infection, responsible for 9.8-33.5% of abortions, stillbirths, and neonatal deaths in horses. Three main types exist based on pathogenesis and lesion distribution.

Clinical Signs of Placentitis

Clinical signs typically appear in late gestation (last trimester). The two hallmark signs are premature mammary gland development and vulvar discharge. Normal udder development begins 2-6 weeks before foaling, with pronounced development in the week immediately preceding parturition. Premature lactation months before expected foaling strongly suggests placental pathology.

  • Premature udder development: Most common presenting sign; may be subtle
  • Vulvar discharge: May be purulent, bloody, or mucopurulent; often missed as mare swishes tail
  • Premature lactation: Streaming of mammary secretions
  • Poor vulvar conformation: Predisposes to ascending infection; assess vulvar seal

Diagnosis

Combined Thickness of Uterus and Placenta (CTUP)

Transrectal ultrasonography measuring CTUP at the cervical star region is the primary diagnostic tool for ascending placentitis. The probe is positioned cranial and lateral to the cervix, measuring from the middle branch of the uterine artery to allantoic fluid at the ventral aspect of the uterine body.

Normal CTUP Values and Abnormal Thresholds

Additional Diagnostic Tools

  • Transabdominal ultrasound: Essential for nocardioform placentitis (lesions at horn base); assess fetal viability, detect twins
  • Speculum examination: Assess cervical integrity and discharge; controversial due to infection risk
  • Serum amyloid A (SAA): Acute phase protein; elevated in placentitis; promising biomarker
  • Mammary secretion electrolytes: Calcium and potassium rise before parturition
  • Progesterone/progestagen levels: May be elevated with placental stress; serial monitoring useful
High-YieldTransrectal ultrasound evaluates the cervical star region (ascending placentitis). Transabdominal ultrasound is required for nocardioform placentitis (horn base lesions). Always measure CTUP from the VENTRAL uterine body - dorsal edema can be physiologic in late gestation.

Treatment of Placentitis

Treatment goals include eliminating infection, reducing inflammation, maintaining uterine quiescence, and supporting pregnancy to term. Multimodal therapy is standard.

NAVLE TipThe classic placentitis treatment triad is: Antibiotics + Altrenogest + Flunixin ("AAF"). Add pentoxifylline for blood flow support. Don't forget to correct vulvar conformation with Caslick procedure - medical therapy alone will fail if bacteria continue to enter!

Prognosis

Retained Fetal Membranes

With prompt, appropriate treatment, prognosis is excellent for survival and future fertility. Mares that recover from uncomplicated RFM do not generally have lower fertility. However, mares that develop metritis, endotoxemia, and/or laminitis have poor to moderate long-term survival prognosis. Foal heat breeding is typically avoided; breed on subsequent cycle.

Placentitis

Prognosis depends on extent of infection, timing of diagnosis, and response to treatment. Early detection and aggressive treatment can result in live foals, though they may be premature, septicemic, or dysmature. Foals born from mares with placentitis should be considered high-risk for neonatal complications. Nocardioform placentitis has the poorest prognosis.

Type Route/Location Common Organisms Characteristic Features
Ascending (Most common) Entry via vulva/cervix; affects cervical star region Streptococcus equi zooepidemicus, E. coli, Klebsiella, Pseudomonas Increased CTUP at cervical star; cervical softening; vulvar discharge
Hematogenous Bloodborne; diffuse or focal lesions at uterine body/horn base Leptospira spp., EHV-1, bacterial septicemia Transabdominal ultrasound better; may have systemic signs
Nocardioform Base of uterine horn(s) and cranial body; NOT cervical star Crossiella equi, Amycolatopsis spp. (gram+, filamentous) Brown, sticky, mucoid exudate with white granules; common in Kentucky; treatment often unrewarding
Gestational Age Normal CTUP Range Abnormal Threshold (Suggests Placentitis)
150-270 days 4-7 mm (minimal change) Greater than 7 mm
271-300 days 5-8 mm Greater than 8 mm
301-330 days 7-10 mm Greater than 10 mm
Greater than 330 days 8-12 mm Greater than 12 mm
Any stage Greater than 17.5 mm = consistent with placentitis
Drug Class Drug/Dose Rationale
Antibiotics Potassium penicillin 22,000 IU/kg IV QID + Gentamicin 6.6 mg/kg IV SID OR TMS 30 mg/kg PO BID (accumulates in allantoic fluid) Broad-spectrum coverage; TMS preferred for outpatient therapy; continue through foaling
Progestogen Altrenogest (Regumate) 0.088 mg/kg PO SID Maintains pregnancy; decreases myometrial contractility; mares will still foal despite treatment
NSAIDs Flunixin meglumine 1.1 mg/kg IV/PO BID Anti-inflammatory; inhibits prostaglandins that cause uterine contractions
Pentoxifylline 8.5 mg/kg PO BID Improves blood flow; rheologic properties; anti-inflammatory
Estradiol cypionate (new) Variable protocols; experimental Increases uterine blood flow; promotes immune response; recent research shows benefit
Surgical Caslick procedure (vulvoplasty) Corrects poor vulvar conformation; prevents ascending infection; CRITICAL for treatment success

Practice NAVLE Questions

Test your knowledge with 10,000+ exam-style questions, detailed explanations, and timed exams.

Start Your Free Trial →